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ABSTRACT
Objective: In this review, we report antimicrobial candidates containing pyrazole nucleus integrated with various functionalities. 
Methods: research results by numerous scientists have been summarized from international journals indexed in reputed database such as Scopus 
and Web of Science. 
Results: Pyrazole derivatives are much of interest as potent bioactive molecules. They have shown large bioactivities especially antimicrobial 
performance against broad spectrum of bacterial strains.
Conclusion: Several designed pyrazole derivates possessed good to superior antimicrobial activities.
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INTRODUCTION
Microbial spread and infection as the major cause of illness in human 
are main problems occurred in both developing and developed 
countries [1-3]. It leads a large number of dead every year [4,5]. This 
condition is deteriorated by the emergence of multidrugs resistance 
(MDR) phenomena. Old antibiotics such as tetracyclines, methicillin, 
aminoglycosides, macrolides, and penicillin have become less and less 
effective day by day [6,7]. For example, drug-resistant Mycobacterium 
tuberculosis and Staphylococcus aureus are found [8,9]. Therefore, 
continuation in developing antimicrobial agents with an attractive 
structural motif and activity toward organic synthesis is a great 
challenge.
Recently, researcher’s attention has been paid to heterocycles containing 
nitrogen atom, particularly pyrazoles and their derivatives [10]. 
They have been found to denote versatile biological activities such 
as monoamine oxidase inhibitor [11,12], antihepatotoxicity [13,14], 
antileishmanial [15-17], anti-inflammatory [18-20], antiproliferative [21], 
tissue non-specific alkaline phosphatase inhibitor [22], cyclin-dependent 
kinase inhibitor [23], anticancer [24-27], antimicrobial [28-30], and 
antioxidant [31-33]. Development of novel chemical structures of 
pyrazole derivatives is currently a trending topic due to their wonderful 
biological actions [34-37]. In this paper, we will focus on the diverse 
structure of pyrazole derivatives and related compounds (e.g. pyrazolines, 
pyrazolinones, and pyrazolones) synthesized in the past few years and 
their performance as potent antimicrobial candidates.
DISCUSSION
Research in 2013
The synthesis of some new pyrazolopyridines from 
4-(dimethylaminomethylene)-1-phenyl-3-(pyridine-3-yl)-1H-
pyrazol-5(4H)-one was investigated by El-Borai et al. [38]. Among 
the synthesized compounds, (1) exhibited remarkable antimicrobial 
activity against Escherichia coli, Enterobacter cloacae, and Serratia with 
inhibition zone diameter of 19, 19, and 17 nm (at 10 mg/ml sample 
concentration), respectively [Fig. 1]. Gaikwad et al. developed three 
series of thiazole-substituted pyrazole derivatives and investigated 
their antimicrobial potency [39]. The result highlighted that compound 
(2) exhibited strong activity against all the tested organism. However, 
compound (3)-(6) showed good action against S. aureus with 
inhibition values of 24.41–27.13 mm (at 128 μg/ml). Introduction 
of F, Cl, Br, and NO2 groups to the phenyl ring enhanced antibacterial 
and antifungal capability [38]. Preparation and characterization of 
novel sulphapiperazine containing arylazopyrazoles were performed 
by Shah et al. [40]. Through antibacterial evaluation, 50 μg/ml of 
compound (7) resulted inhibition zone diameter of 84, 54, 80, 67, and 
70 mm against Bacillus subtilis, S. aureus, Salmonella typhi, and E. coli, 
respectively. It was denoted as the most active agent in this series. At 
1000 μg/ml, compound (7) also showed the highest antifungal activity 
with an inhibition zone of 78, 76, 77, 66, and 64 mm against Penicillium 
expansum, B. theobromine, Nigrosspora sp., Trichothesium sp., and 
R. nigricun, respectively [40].
A novel bioactive thiazolyl-pyrazoline derivatives were designed by 
Sharifzadeh et al. through one-pot three-component reactions [41]. 
Compounds (8) and (9) were noted to have moderate activity against 
Pseudomonas aeruginosa with inhibition zone diameter of 19 mm at 
sample concentration of 1000 μg/ml. Three series of new 1, 2, 4-triazoles 
and benzoxazoles containing pyrazole moiety were investigated in term 
of their antimicrobial performance [42]. Among the screened products, 
compounds (10) and (11) which contain 2, 5-dichlorothiophene and 2, 
4-dichlorophenyl substituent, respectively, on pyrazole ring emerged 
as potent antimicrobial agents. These compounds have minimum 
inhibition concentration (MIC) values in the range of 1.6125–6.2500 
μg/ml against five tested microbes. Some new pyrazolinone and 
pyrazole analogs containing quinoline nucleus were synthesized by 
Amir et al. [43]. From antimicrobial evaluation result, compound (12) 
was denoted as the most excellent agent with MIC values of 6.25 μg/
ml (against E. coli, Aspergillus niger, and Candida albicans) and 12.5 μg/
ml (against S. aureus). Compounds bearing electron withdrawing group 
such as fluoro and bromo at phenyl ring substituent of pyrazolinone and 
pyrazole nucleus showed better activity than compounds with electron 
donating group [43]. Compound (13) was chosen as the most potent 
antimicrobial agent in a new series of 6-amino-1-(1,3-diphenyl-1H-
pyrazole-4-yl)methyleneamino)-4-(aryl)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitriles [44]. The synthesis of some novel pyrazole and 
pyrazole derivatives bearing benzensulfonamide moiety was done 
by Hassan [45]. Compound (14) exhibited the highest activity against 
C. albicans strains with MIC value of 12.5 μg/ml. New derivatives of 
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pyrazole-3-carboxylates, 1, 3, 4-oxadiazoles and 5-aminopyrazole-4-
carboxylates were synthesized by Siddiqui et al. [46]. Furthermore, 12 
novel compounds were also screened for their antimicrobial efficacy. 
Compound (15) was observed to denote significant activity against 
A. niger with MIC value of 12.5 μg/ml. It has the same performance with 
standard drug clotrimazole.
Research in 2014
A new series of 2-H/methyl-3-phenyl-5-alkyl/aryl/heteroaryl-7-
trifluoromethylpyrazolo (1,5-a) pyrimidines were developed by 
Aggarwal et al. and were tested for their antimicrobial activity [47]. All 
tested compounds possessed moderate antibacterial activity against S. 
aureus and B. subtilis as Gram-positive bacteria [Fig. 2]. Among them, 
compounds (16) and (17) were selected as the most potent agent 
with inhibition zone diameter between 15.6 and 19.3 mm. Kumar 
et al. synthesized some new pyrimidine pyrazole heterocycles [48]. 
Following antifungal evaluation, compounds (18) and (19) showed 
synergy with standard drug ketoconazole at 1:8 (6.25:50.0 μg/ml) 
and 1:4 (25:100 μg/ml) against Aspergillus fumigatus (ITCC 4517) and 
A. fumigatus (VPCI 190/96), respectively.
Lavanya et al. reported the synthesis of some novel (1,4-phenylene) 
bis (arylsulfonylpyrazoles and isoxazoles) by 1,3-dipolar cycloaddition 
of nitrile imines and nitrile oxides [49]. In pyrazole series, compound 
(20) exhibited promising activity against both of Gram-positive and 
Gram-negative bacteria. However, among the synthesized compounds, 
the study revealed that compound which contains isoxazole nucleus 
has better activity than compound with pyrazole ring. Malladi et al. 
developed new analogs of 2,5-disubstituted-1, 3, 4-oxadiazoles bearing 
pyrazole skeleton [50]. Following in vitro evaluation of antimicrobial 
performance, compounds (21) and (22) were noted to have appreciable 
activity against E. coli, S. aureus, and P. aeruginosa strains with diameter 
of zone inhibition in the range of 9–13 mm. These compounds also 
showed remarkable antifungal activity against different strains of 
Aspergillus flavus, C. keratinophilum, and C. albicans [50].
One-pot multicomponent synthesis and biological benefit of some 
new quinazolin-4(3H)-one integrated with 1,3-diphenyl-1H-pyrazole 
system were studied by Mehta et al. [51]. Among the prepared 
compounds, compound (23) was chosen as the most prominent agent 
against some Gram-positive and Gram-negative bacteria. Furthermore, 
this compound exhibited excellent action as anti-M. tuberculosis with 
98% of inhibition using Rifampicin and Isoniazid as positive controls. 
From a novel series of 2-(5-methyl-1,3-diphenyl-1H-pyrazole-4-yl)-5-
phenyl-1,3,4-oxadiazoles developed by Ningaiah et al., compound (24) 
was selected as the most potent antimicrobial agent [52]. Compound 
(25) showed most excellent antibacterial activity in a new series 
of 5-(thiophen-2-yl)-phenyl pyrazolines synthesized by Rani and 
Mohamad [53]. The hybrid of pyrazole-quinoline-pyridine as a novel 
class of antimicrobial candidates was developed by Sangani et al. [54]. 
Based on antimicrobial evaluation in term of MIC values, compounds 
(26) and (27) were denoted as the most promising candidates. Mishra 
et al. studied the synthesis and antibacterial action of 3-substituted 
pyrazole derivatives [55]. Compound (28–30) showed moderate 
to feeble inhibition against both Gram-positive and Gram-negative 
bacteria.
Research in 2015
Polysubstituted and condensed pyrazolopyranopyrimidine and 
pyrazolopyranotriazine were developed by Hafez et al. and were 
subsequently found to exhibit activity against certain microbial strains 
[56]. Compound (31) was the most active antifungal agent. It has 
better performance than fluconazole [Fig. 3]. Meanwhile, compound 
(32) exhibited excellent activity against bacteria which was higher or 
equal to MIC of norfloxacin [56]. Synthesis and antimicrobial screening 
of acetyl sulfonamide pyrazoles, substituted 4,5-dihydropyrazole-1-
carbothioamide and 4,5-dihydropyrazole-1-isonicotinoyl derivatives 
were presented by Hamada and Abdo [57]. Compound (33) showed 
most potent activity against S. aureus and C. albicans with inhibition 
zones of 21 and 24 mm, respectively. The presence of pharmacophores 
Fig. 1: Structure of compounds (1)–(15)
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Fig. 2: Structure of compounds (16–30)
Fig. 3: Structure of compounds (31–47)
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with lipophilic properties such as chloro and bromo enhances the 
antimicrobial efficacy.
A remarkable antibacterial effect against S. pneumoniae, E. faecalis, and 
H. influenzae of (34) was recorded by İskeleli et al. [58]. Unfortunately, it 
has no antifungal effect for selected fungal isolates. The multicomponent 
cyclo-condensation reaction of 1-phenyl-3-(2-(tosyloxy)phenyl)
propane-1,3-dione, N,N-dimethylformamide dimethyl acetal and 
hydrazine or hydroxylamine hydrochloride or 2-aminothiophenol or 
2-aminophenol or benzene-1,2-diamine was used to prepare some 
novel pyrazole, isoxazole, and other heterocyclic models [59]. In 
pyrazole series, compound (35) was denoted to give appreciable activity 
against all tested microbes. Compound (36) has similar performance to 
compound (35) except against fungi Fusarium oxysporum; no effect was 
observed [59]. Preparation and biological testing of 1,3-diaryl pyrazoles 
bearing aminoguanidine or furan-2-carbohydrazide functionalities 
have been done by Li et al. [60]. Most of the prepared compounds 
exhibited promising action against several Gram-positive and Gram-
negative bacteria with MIC values between 1 and 64 μg/ml. Specifically, 
compounds (37–39) were highlighted as the most active candidates 
against both bacterial and fungal strains with MIC values of 1 or 
2 μg/ml. A novel series of pyrazoles decorated with 2-chloroquinoline 
nucleus have been synthesized and evaluated for antimicrobial activity 
by Miniyar et al. [61]. Among the series, compound (40) moderately 
inhibited A. fumigatus, P. notatum, and B. subtilis with MIC 48, 46, and 
44 μg/ml, respectively, whereas compound (41) was noted as an active 
agent against E. coli, P. notatum, and B. subtilis with MIC 43, 57, and 
54 μg/ml, respectively [61].
Nayak et al. successfully designed a novel series of isonicotinohydrazide 
based pyrazole derivatives [62]. Following in vitro evaluation 
of antibacterial activity, three derivatives (42–44) showed high 
performance against the tested bacteria having zone inhibition in the 
range of 15–25 mm. Raundal et al. have synthesized and characterized 
novel 1,5-disubstituted pyrazole and isoxazole derivatives [63]. All 
the prepared compounds have been investigated for the antibacterial 
and antifungal potency. Interestingly, all the tested samples perform 
good activity, however, compound (45) possess highest performance. 
In the study conducted by Viveka et al., the design synthesis and 
antibacterial activity of some novel pyrazolyl-pyrazolines have been 
developed [64]. The bioactivity test revealed that compound (46) 
that contains N-propionyl pyrazolyl-pyrazoline could be identified 
as the most promising candidate for an antibacterial agent with zone 
inhibition diameter within 15–28 mm against Gram-positive and Gram-
negative bacteria. The compounds with multi-pyrazole nucleus and 
their application as antibacterial agents have been synthesized and 
evaluated by Wang et al. [65]. Compound (47) was found to be the most 
active with superior area of zone inhibition of 431.81 and 222.14 mm 2 
against S. aureus and B. subtilis, respectively.
Research in 2016
Phenyl-pyrazolines and isoniazid-pyrazolines were prepared by 
Ahmad et al. starting from p-acetamidophenol initial substrate [66]. 
Newly obtained pyrazolines showed interesting antibacterial activity 
toward bacterial and fungal strains [Fig. 4]. Specifically, compound 
(48) exhibited excellent antibacterial potency against S. aureus and P. 
aeruginosa with MIC 3.12 μg/mL. On the other hand, compound (49) 
has been identified as the most potent antifungal performance against 
A. niger and C. albicans (MIC 3.12 μg/mL) [66]. Akondi et al. described 
the in water synthesis of pyrazolone derivatives containing 2-naphtol 
skeleton using Ce/SiO2 composite catalyst [67]. Overall, compound 
(50) was recorded as the most potent antimicrobial candidate through 
in vitro assay against Micrococcus luteus, B. subtilis, Salmonella paratyphi, 
S. typhi, C. albicans, and Trichoderma viride with zone of inhibition 
between 20 and 28.5 mm. In addition, it moderately inhibits the 
growth of S. mutans and P. aeruginosa (14.5 and 13.5 mm, respectively). 
Pyrazole compounds integrated with 1,4-benzothiazine moiety have 
been developed by Dabholkar and Gavande [68]. Through antimicrobial 
assay, compound (51) was found to be the most promising candidate 
in this series against some Gram-positive, Gram-negative bacteria, and 
fungi with zone of inhibition in the range of 10–17 mm.
Fig. 4: Structure of compounds (48–60)
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Antimicrobial assessment was carried out for newly synthesized 
pyrazole derivatives containing oxa/thiadiazolyl or pyrazolyl moieties 
and pyrazolopyrimidine derivatives [69]. Among the prepared 
compounds, there were seven candidates that showed excellent activity 
compared to standard drug. However, compound (52) was selected as 
the best agent. Surendra Kumar et al. explored the synthesis of novel 
pyrazole analogs and screened them for antimicrobial potency [70]. 
Compound (53) was found to be the most promising candidate against 
Gram-negative bacterial strain of E. coli (MIC 0.25 μg/mL and zone of 
inhibition 28 mm). Quinoline-pyrazole hybrid derivatives containing 
fluorine moiety were synthesized and screened for antibacterial 
activity by Nayak et al. [71]. From in vitro test, it was found that 
compound (54–57) exhibited substantial inhibitory activity against 
bacterial strains with inhibition zone diameter within 15-24 mm. 
Refat and Fadda reported the synthesis and antimicrobial activity of 
some novel hydrazide, pyrazole, triazine, isoxazole, and pyrimidine 
derivatives [72]. Surprisingly, pyrazole (58) was denoted as the most 
potent compound within this research result. It could be concluded 
that pyrazole is one of the lead compounds for antimicrobial agent. 
A series of Schiff ’s bases of substituted (4E)-4-(benzylideneamino)-
1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-ones have been prepared 
starting from 4-AAP and benzaldehyde derivatives [73]. Based on 
Kirby–Bauer protocol for antimicrobial assay, it was noted that 
compounds (59) and (60) exhibited the high activity against bacterial 
as well as fungal strains, such as B. subtilis, P. aeruginosa, and A. niger. 
Schiff ’s bases containing 4-Cl and 4-NO2 moieties presented good 
inhibitory activity [73].
Research in 2017
Ahn et al. reported the first route to pyrazole-arginine derived from 
novel synthesized N-alkyl/aryl pyrazole amino acids [74]. Compound 
(61) proved to be a promising lead compound of antimicrobial agent 
against MDR bacteria, such as methicillin-resistant S. aureus (MRSA), 
MDR P. aeruginosa (MDRPA), and vancomycin-resistant Enterococcus 
faecium (VREF) strains [Fig. 5]. Compared to melittin as reference 
drug, it showed 2-folds, 2-4-folds, and 4-folds of better activity against 
MRSA, MDRPA, and VREF, respectively. A superior antimicrobial activity 
with zone of growth inhibition up to 85 mm against Acinetobacter 
baumannii was displayed by 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)
benzoic acid, a compound in a series prepared by Allison et al. [75]. 
A new series of pyrazole derivatives containing 2-thioxothiazolidine-4-
one were studied by Bhatt and Sharma [76]. Antimicrobial evaluation 
of the synthesized products revealed that compounds (63–65) were 
found as promising candidate for anti-S. aureus activity. Furthermore, 
compound (66) showed a potent activity against E. coli strains. 
Meanwhile, a very good activity against C. albicans was showed by 
compound (64) and (67). Chougala et al. developed an eco-friendly 
and green method of multicomponent reaction for the synthesis 
of coumarin-based pyrano [2,3-c]pyrazole derivatives [77]. All 
synthesized compounds have shown the interesting result to be drug 
candidates. Compound (68) was found having excellent activity against 
Gram-positive and Gram-negative bacteria (minimum inhibitory 
concentration [MIC] 0.78–6.25 μg/mL).
Mehta et al. developed new mono and bisphenyl integrated 
bispyrazole and bispyrazolone derivatives, then evaluated 
their antimicrobial performance [78]. Compound (69) and (70) 
demonstrated good inhibitory activity against some bacterial strains 
with zone of inhibition in the range of 19–27 mm. The title compound 
1-(3-chlorophenyl)-3-(5-chlorothiophen-2-yl)-5-phenyl-4,5-dihydro-
1H-pyrazole was prepared and screened for antimicrobial activity by 
Prabhudeva et al. [79]. In vitro test of the ligand (71) revealed that 
this compound has moderate inhibitory activity against B. subtilis 
and A. flavus. Meanwhile, against S. aureus and E. coli, it showed good 
performance with MIC 20 μg/mL, same with Streptomycin as positive 
control. A novel class of 3-(benzofuran-2-yl)-5-(4-methoxyphenyl)-
4,5-dihydro-1H-pyrazole derivatives was designed by Rangaswamy 
et al. [80]. Using well plate method for antimicrobial assay, compound 
(72) and (73) exhibited good inhibitory activity against E. coli, 
S. aureus, and P. aeruginosa.
CONCLUSION
Several developed pyrazole derivatives possessed good to superior 
antimicrobial activities. This current review provides important 
information for the upcoming design of new antimicrobial agents based 
pyrazole skeleton.
Fig. 5: Structure of compounds (61–73)
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